Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stroke 2Prostatic Neoplasms 2Osteoporosis 2Neoplasms 2Kidney Diseases 2Hypertension 2Heart Failure 2Frailty 2Diabetes Mellitus 2Colorectal Neoplasms 2Cardiovascular Diseases 2Arthritis 2Weight Loss 1Rectal Neoplasms 1Obesity-Related Malignant Neoplasm 1Obesity 1Neoplasm Metastasis 1Motor Activity 1Lung Neoplasms 1Digestive System Carcinoma 1Colonic Neoplasms 1Chronic Disease 1Bone Diseases, Metabolic 1

Interventions

Leucovorin 38Fluorouracil 36Oxaliplatin 34Bevacizumab 34Irinotecan 32Cetuximab 23Capecitabine 18Panitumumab 14IFL protocol 7Folfox protocol 6Celecoxib 6Radiotherapy 5Nivolumab 5Magnetic Resonance Spectroscopy 5Immunohistochemistry 5Gene Expression Profiling 5regorafenib 4pembrolizumab 4dehydroftorafur 4Ramucirumab 4Fluorodeoxyglucose F18 4Floxuridine 4aflibercept 3Surgical Procedures, Operative 3Sorafenib 3Radiosurgery 3Ipilimumab 3Gemcitabine 3Fentanyl 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Colonic Neoplasms × Nutrition Assessment × Clear all
NCT05746195 2026-01-22

Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)

University of California, San Francisco

Phase NA Completed
46 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡